(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Ahead of Earnings: Tilray Brands, Accolade, and AngioDynamics in the Spotlight

  • September 30th, 2023
  • 388 views

Some of the companies expected to report financial results on Wednesday, October 4, are:

Tilray Brands, Inc. (Nasdaq: TLRY), a company in the cannabis industry, is scheduled to release its first-quarter fiscal 2024 financial results before the market opens. 

Analysts are forecasting a loss of $0.05 per share on revenue of $174 million. 

On Friday, $TLRY closed at $2.39, up $0.04 (+1.70%).

Accolade, Inc. (Nasdaq: ACCD), a provider of personalized healthcare solutions, will unveil its fiscal second-quarter 2024 financial results after the market closes. 

The consensus estimate points to a loss of $0.54 per share, accompanied by revenue reaching $94.09 million. 

$ACCD closed at $10.58 on Friday, reflecting a decrease of $0.18 (-1.67%).

AngioDynamics, Inc. (Nasdaq: ANGO), a medical device company, is set to report financial results for the first quarter of fiscal year 2024 before the market opens. 

Analysts expect a loss of $0.13 per share on revenue of $77.69 million. 

On Friday, $ANGO closed at $7.31, down $0.01 (-0.14%).

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13